Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.100 |
None |
0.967 |
92 |
|
1996 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.400 |
None |
0.988 |
82 |
|
1991 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
0.986 |
72 |
|
1994 |
2020 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.100 |
None |
0.967 |
61 |
|
2012 |
2020 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.907 |
54 |
|
2000 |
2020 |
Secondary malignant neoplasm of bone
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
647
|
18
|
0.100 |
None |
0.935 |
46 |
|
2002 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
0.951 |
41 |
|
1995 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.100 |
None |
0.951 |
41 |
|
1995 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
1.000 |
37 |
|
1995 |
2020 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.100 |
None |
0.900 |
30 |
|
1992 |
2020 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.100 |
None |
0.893 |
28 |
|
2013 |
2020 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.100 |
None |
0.963 |
27 |
|
2003 |
2020 |
Prostatic Diseases
|
group |
Male Urogenital Diseases
|
Disease or Syndrome
|
72
|
4
|
0.100 |
None |
0.889 |
18 |
|
1994 |
2020 |
Lower Urinary Tract Symptoms
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
77
|
30
|
0.100 |
None |
1.000 |
17 |
|
2001 |
2019 |
Salivary Gland Pleomorphic Adenoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
63
|
9
|
0.100 |
None |
0.938 |
16 |
|
1994 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.100 |
None |
1.000 |
15 |
|
1998 |
2020 |
Non-metastatic prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
18
|
|
0.100 |
None |
1.000 |
13 |
|
2017 |
2020 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.100 |
None |
0.846 |
13 |
|
1990 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.100 |
None |
1.000 |
12 |
|
1995 |
2011 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.100 |
None |
1.000 |
11 |
|
2017 |
2020 |
prostatitis
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
86
|
1
|
0.100 |
None |
0.909 |
11 |
|
2000 |
2019 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.100 |
None |
0.900 |
10 |
|
2002 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.100 |
None |
0.900 |
10 |
|
2017 |
2020 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.090 |
None |
1.000 |
9 |
|
2009 |
2019 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.090 |
None |
0.556 |
9 |
|
1995 |
2019 |